Equities

Bellevue Healthcare Trust PLC

Bellevue Healthcare Trust PLC

Actions
  • Price (EUR)1.63
  • Today's Change0.01 / 0.62%
  • Shares traded0.00
  • 1 Year change+24.43%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Bellevue Healthcare Trust PLC's revenues fell 290.64% from -27.63m to -107.95m. a loss of 41.42m to a larger loss of 121.04m.
Gross margin--
Net profit margin--
Operating margin--
Return on assets-3.71%
Return on equity-3.88%
Return on investment-3.88%
More ▼

Cash flow in GBPView more

In 2023, Bellevue Healthcare Trust PLC increased its cash reserves by 139.29%, or 64.59m. Cash Flow from Investing totalled 230.63m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 6.54m for operations while cash used for financing totalled 159.69m.
Cash flow per share--
Price/Cash flow per share--
Book value per share1.50
Tangible book value per share1.50
More ▼

Balance sheet in GBPView more

Bellevue Healthcare Trust PLC uses little debt in its capital structure as supported by a debt to capital ratio of 1.67%.
Current ratio2.53
Quick ratio--
Total debt/total equity0.017
Total debt/total capital0.0167
More ▼

Growth rates in GBP

SmartText is unavailable
Div yield(5 year avg)3.59%
Div growth rate (5 year)8.41%
Payout ratio (TTM)--
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-127.87
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.